Scilex Holding Company (SCLX)
Nasdaq: SCLX · Biological Products, (No Diagnostic Substances) · Palo Alto, CA · filing with the SEC since 2020
Filings
649 filings since 2017 beside 93 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 30, 2026.
Filings a yearinsider forms included
52611221017915852
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Dec 11, 2025.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Dec 6, 2024.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Nov 22, 2024.SEC letters: 16 in the last 36 months, the newest Jun 9, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jul 22, 2026
8-K items 1.01, 2.01, 9.01
Major agreement signed; Purchase or sale of a business completed · Current report
Jul 18, 2026
Jul 6, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jul 3, 2026
Jun 29, 2026
8-K items 1.01, 3.02
Major agreement signed; Shares sold without registration · Current report
Jun 24, 2026
May 5, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 4, 2026
Feb 20, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Feb 19, 2026
40 of 649 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.